Semaglutide (Semaglutide) is an FDA-approved prescription medication since December 2017 (Ozempic), June 2021 (Wegovy) manufactured by Novo Nordisk. It is used for best weight loss injections.

How much does Semaglutide cost?

The estimated cost of Semaglutide is $900 - $1,500 per month (varies by formulation and insurance) without insurance. Insurance coverage and savings programs may reduce your out-of-pocket cost.

What are the side effects of Semaglutide?

Common side effects include: Nausea, Diarrhea, Vomiting, Constipation, Abdominal pain. Consult your doctor about any concerns.

How effective is Semaglutide for weight loss?

Clinical studies show an average weight loss of 15-20% of body weight (Wegovy), 10-15% (Ozempic) with Semaglutide.

This content is for informational purposes only. BestMedsHub may receive compensation from affiliate links. Always consult a healthcare professional before starting any medication.

FDA Approved — December 2017 (Ozempic), June 2021 (Wegovy) Generally available, but Wegovy may have supply constraints

Semaglutide

Semaglutide — Novo Nordisk

Updated Mar 26, 2026

Avg. Weight Loss 15-20% of body weight (Wegovy), 10-15% (Ozempic)

Monthly Cost $900 - $1,500 per month (varies by formulation and insurance)

Clinical Success 83% of participants lost ≥5% body weight (Wegovy), 60-70% (Ozempic)

Prescription Required

Get Semaglutide Online

Consult with a licensed provider and get your prescription delivered to your door.

Start Consultation

Pros

FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic)
Highly effective for weight loss (15-20% with Wegovy, 10-15% with Ozempic)
Once-weekly injection is convenient
Strong clinical evidence supporting effectiveness
May improve cardiovascular health markers
Pre-filled pen is easy to use
Multiple formulations available (injectable and oral)
Longer safety track record than newer medications

Cons

Expensive without insurance ($900-$1,500/month)
Requires weekly injections (for injectable forms)
Common gastrointestinal side effects (nausea, vomiting, diarrhea)
May have supply shortages, especially Wegovy
Not suitable for people with certain medical conditions
Must be stored in refrigerator (injectable forms)
Ozempic not FDA-approved specifically for weight loss alone

Who Should Use Semaglutide?

Recommended For

Adults with obesity (BMI u226530) seeking weight loss
Adults with overweight (BMI u226527) with weight-related conditions
People with type 2 diabetes seeking weight loss (Ozempic)
Those who prefer once-weekly dosing
People seeking proven, well-established weight loss medication
Those whose insurance covers weight management medications

Not Recommended For

People with history of medullary thyroid carcinoma
Pregnant or breastfeeding women
People with severe gastrointestinal disease
Those who cannot afford medication without insurance coverage
People seeking weight loss without diabetes (if using Ozempic off-label)

Dosage Schedule

Standard titration schedule for Semaglutide.

0.25 mg

Weekly (starting dose) · Subcutaneous injection (Wegovy/Ozempic) or oral tablet (Rybelsus)

0.5 mg

Weekly (after 4 weeks) · Subcutaneous injection

1.0 mg

Weekly (maintenance dose for Ozempic) · Subcutaneous injection

2.4 mg

Weekly (maintenance dose for Wegovy) · Subcutaneous injection

Safety & Side Effects

Important safety information for Semaglutide.

Common Side Effects

Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Dizziness Indigestion

Serious — Seek Medical Help

Pancreatitis Gallbladder problems Kidney problems Low blood sugar (hypoglycemia) Allergic reactions Increased heart rate Diabetic retinopathy complications (in diabetes patients)

Do Not Use If:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Pregnancy
• Severe gastrointestinal disease
• Type 1 diabetes (for diabetes formulations)

Warnings

• Risk of thyroid C-cell tumors
• Do not use with other GLP-1 receptor agonists
• May cause low blood sugar when used with insulin or sulfonylureas
• Monitor for diabetic retinopathy in diabetes patients

Pricing & How to Get It

Monthly Cost (without insurance) $900 - $1,500 per month (varies by formulation and insurance)

Insurance Wegovy: Covered by most insurance plans when criteria are met. Ozempic: Typically covered for type 2 diabetes; off-label weight loss use may not be covered.

Savings Programs

Novo Nordisk Wegovy Savings Card (may reduce cost to $0 for eligible patients)

Novo Nordisk Ozempic Savings Card (may reduce cost to $25/month for eligible patients)

Patient assistance programs available

Prescribing Providers

Trim Rx 9.9/10

Visit

Medvi 9.8/10

Visit

Mochi Health 9.6/10

Visit

About Semaglutide

Affiliate Disclosure: This content contains affiliate links to health providers and services. BestMedsHub may receive compensation when you click through and take action. This compensation may impact how and where products and providers appear on this site. BestMedsHub does not include all providers or products available in the marketplace. This information is not medical advice — always consult a qualified healthcare professional.

Semaglutide is a GLP-1 receptor agonist medication available in multiple formulations (Wegovy, Ozempic, Rybelsus) for weight management and type 2 diabetes. It’s one of the most effective weight loss medications available, with proven results in clinical trials.

Compare Other Medications

See how other FDA-approved weight loss medications compare.

Finasteride

Minoxidil

Mounjaro (Tirzepatide): Cost, Dosing & How to Get It 2026

Ozempic

Semaglutide ·Novo Nordisk

FDA

Weight Loss 10-15% of body weight

Monthly Cost $900 - $1,200 per month

View all medications →

Important: Semaglutide is a prescription medication. Do not use without consulting a licensed healthcare provider. This page is for informational purposes only. Individual results may vary.